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The volume dependence of single breath carbon monoxide diusing capacity (DLCO) and carbon monoxide
transfer coecient (KCO) was determined in 24 healthy subjects. The change in DLCO [fraction of DLCO measured
at total lung capacity (TLC)] to change in alveolar volume [fraction of alveolar volume (VA) at TLC] closely fitted a
simple linear regression and matched a theoretical model. As VA decreased, DLCO fell linearly and KCO increased
as expected from the relation of DLCO to VA. The equations for adjustment of predicted DLCO and KCO for
alveolar volume are:
DLCO=DL COtlc  058 042VA=VAtlc
KCO=KCOtlc  042 058=VA=VAtlc
DLCO and KCO were evaluated in 2313 patients. Subgroups of patients with asthma, emphysema, extrapulmonary
lung disease, interstitial lung disease and lung resection were identified. Unadjusted DLCO and KCO percent
predicted values showed large dierences and much variability, so can be misleading. As expected, KCO and DLCO
percent predicted values adjusted for alveolar volume were nearly identical. Subgroups have characteristic patterns
of VA and unadjusted and adjusted DLCO and KCO. Changes in DLCO and KCO with alveolar volume are
relevant for accurate interpretation of diusion in patients with low lung volumes. Adjusting predicted DLCO and
KCO for alveolar volume provides a better assessment of lung function.
Key words: asthma; DLCO; DLCO=VA; emphysema; interstitial lung disease; KCO; lung volume; normals;
sarcoidosis.
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Carbon monoxide diusing capacity (DLCO) has been
shown to be a sensitive indicator of gas exchange, being
abnormal in patients with interstitial lung disease, pulmo-
nary vascular lung disease and emphysema. The single
breath technique also determines the volume (VA) of
helium distribution. The ratio DLCO/VA, or KCO,
measures diusing capacity per litre alveolar volume.
Uptake of CO can be aected by factors other thanReceived 2 June 1998 and accepted in revised form 24 February
1999.
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0954-6111/00/010028+10 $35?00/0intrinsic lung disease. Anemia lowers DLCO (1,2,3).
Exercise increases DLCO (4,5). Pulmonary hemorrhage
can elevate DLCO (6).
Predicted DLCO values are traditionally adjusted for age,
height, sex and race. In an attempt to have DLCO %
predicted provide information about lung function inde-
pendent of hemoglobin. The American Thoracic Society (7)
recommends that DLCO values be adjusted for hemoglobin.
Another factor which influences both DLCO and KCO is
lung volume. However, the ATS has not recommended that
predicted DLCO or KCO be adjusted for lung volume.
There is much confusion over how to adjust predicted
values of DLCO and KCO for lung volume, with
investigators using widely varying methods (8,9,10). This
has contributed to confusion and controversy about how to
interpret DLCO and KCO as measures of lung function.
This study was designed to show how lung volume aects
DLCO and KCO in healthy subjects, propose a method for# 2000 HARCOURT PUBLISHERS LTD
ADJUSTING DLCO AND KCO FOR ALVEOLAR VOLUME 29adjusting predicted DLCO and KCO values for alveolar
volume, and then apply this to a broad patient population.
Subgroups of patients were identified to determine if
patterns of DLCO, KCO and VA exist for particular
pulmonary conditions.
Methods
NOMENCLATURE
Alveolar volume, or VA, is the volume of distribution of
helium, expressed in body temperature and pressure
saturated (BTPS) units, from a single-breath DLCO test.
KCO equals DLCO/VA. Predicted or percent predicted
DLCO and KCO unadjusted for alveolar volume indicate
the predicted or percent of predicted values measured at
TLC. Predicted or percent predicted DLCO and KCO
adjusted for alveolar volume indicate the predicted or
percent of predicted values adjusted for the subject’s VA.
DLCO and KCO adjusted for alveolar volume can also be
called DLCO and KCO adjusted for VA.
PREDICTED VALUES
Prediction equations were used for forced expiratory
volume in 1 sec (FEV1), FEV1/vital capacity (VC), VC
(11), TLC (12) and DLCO (13). While there is no consensus
on how to adjust predicted values for ethnic dierences
(14), predicted values for FEV1, VC, TLC, DLCO and VA
were reduced by 10% for blacks. If the hemoglobin was
known, the predicted DLCO was adjusted (1). Predicted VA
was calculated from equations for TLC (12) from which
predicted dead space was subtracted. The predicted dead
space (ml BTPS) equals 132 Height (cm) 086 Age (years)
7110, which is based on an equation of Harris et al. (15).
The predicted KCO equals predicted DLCO/predicted VA.
The predicted DLCO and KCO adjusted for alveolar
volume use the regression equations determined in this
study of healthy subjects to adjust the predicted value for
the patient’s VA.
Alternative methods to calculate predicted KCO used
equations derived from single breath DLCO measurements
for alveolar volume and for KCO. Miller et al. (13) provides
equations for single breath TLC and single breath DLCO/
TLC among non-smokers. These were adjusted for dead
space to yield predicted KCO equals predicted DLCO/
predicted VA (with VAsingle breath; TLCdead space);
and to yield predicted KCO equals predicted DLCO/TLC *
TLC/VA.
DLCO test
The subjects took a deep breath in, expired to residual
volume, inspired rapidly a gas mixture containing approxi-
mately 03% CO, 10% He, 21% O2, balance N2, held their
breath for about 9 sec and then expired rapidly. Maneuvers
were performed using a P.K. Morgan Transfertest (Morgan
Medical Ltd., Rainham, U.K.). Alveolar samples werecollected after the washout volume was discarded. To
ensure sucient alveolar sample for measurements, the
alveolar sample was 09 l for expected inspired volumes
415 l, 06 l for volumes 12–15 l and 05 l for volumes
512 l. The washout was 09 l for expected inspired
volumes 421 l, 05 l for volumes 17–21 l and 03 l for
volumes 517 l The interval between consecutive measure-
ments was at least 5 min. Helium and CO were measured in
the inspired gas and alveolar sample. Inspired volume was
measured from a paper kymograph with 50 ml resolution.
CALCULATION OF VI, VA, DLCO AND KCO
Inspired volume (VI), alveolar volume (VA), diusing
capacity (DLCO) and KCO (DLCO/VA), were calculated
from the inspired volume [atmospheric pressure tempera-
ture dry (APTD)], room temperature, barometric pressure
and inspired and alveolar sample concentrations of He and
CO using estimated values for dead space and for alveolar
PCO2 (7). CO backpressure was ignored in the calculation
of DLCO.
NORMAL SUBJECTS
In 24 healthy non-smokers, values of VA, DLCO and KCO
at functional residual capacity (FRC), total lung capacity
(TLC) and two intermediate volumes were determined after
informed consent. Subjects were required to have no known
respiratory or cardiac disease, and have FEV1, FVC, TLC
and DLCO values above 75% predicted. The group
consisted of 13 males and 11 females with ages ranging
from 24–66 years (40+12) (mean+SD).
Procedure in study of normals
Spirometry (FEV1, FVC) and expiratory reserve volume
were measured using a P.K. Morgan rolling seal spiro-
meter. The best FEV1 and FVC were chosen from three
eorts, and the average expiratory reserve volume (ERV) of
two tests was used. Functional residual capacity (FRC) was
determined by plethysmography. DLCO and KCO were
determined at lung volumes near FRC, FRC 1/3
inspiratory capacity (IC), FRC 2/3 IC, and TLC. The
subjects aimed for the targeted volume by observing a
digital display of volume inspired. The order of the testing
was selected randomly without repeats from the 24 possible
test sequences. After completing these four maneuvers, a
final DLCO test was performed at TLC.
Eect of lung volume on DLCO and KCO
The average of the two measurements at TLC provided
DLCOtlc, VAtlc and KCOtlc. The DLCO, VA and KCO
measured at the three other lung volumes for each subject
were expressed as a fraction of the TLC value.
FIG. 1 DLCO and KCO vs. VA in 24 normal subjects
expressed as fraction of value measured at TLC. Linear
regression equations are DLCO/DLCOtlc058042 VA/
VAtlc; and KCO/KCOtlc043057 (VA/VAtlc). (For
abbreviations see text.) : DLCO; ^: KCO.
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A model to predict the dependence of DLCO and KCO on
VA is to use the relationship 1/DLCO1/Dm1/Vc, where
 equals the rate of CO uptake by blood, Dm equals the
membrane conductance component of DLCO, and Vc
equals the pulmonary capillary blood volume. This relates
diusion to the components of membrane diusion and
pulmonary blood volume. Solving the equation 1/DLCO=
1/DM+1/Vc, yields DLCODm*Vc/(Vc Dm). If Vc
stays constant as lung volume changes (16), and Dm
increases by kVA2/3, then the relationship becomes DLCO
Dm VA2/3*Vc/(VcDm VA2/3).
PATIENTS
All patients studied in the pulmonary function laboratory
at a large teaching hospital who had both spirometry and
DLCO results on our on-line data base were included. Two
thousand three hundred and thirteen patients were identi-
fied. The most recent DLCO for each patient was analyzed,
along with spirometry and plethysmography results from
the same day. Most patients had two or three DLCO
measurements. Mean DLCO and VA values were used.
Subsets of patients were determined by pulmonary
function test (PFT) criteria, and by a recorded diagnosis
of sarcoidosis. PFT criteria for obstruction were
FEV1560% predicted and FVC1/VC570% predicted.
Criteria for elevated lung volumes was TLC4105%
predicted, or if plethysmography was not done VA480%
predicted. Restriction was present if TLC580% predicted,
or if plethysmography was not done VA575% predicted.
Normal diusion for alveolar volume was defined as
DLCO480% predicted for alveolar volume, while low
diusion for alveolar volume was DLCO575% predicted
for alveolar volume.
PFT criteria were used to identify patients with probable
emphysema, asthma, interstitial lung disease and extra-
pulmonary cause for low lung volume. Emphysema was
identified as obstruction, elevated lung volumes and low
diusion for alveolar volume. Interstitial lung disease was
identified as low VC without obstruction (VC585%
predicted and FEV1/VC490% predicted), restriction and
low diusion for alveolar volume. Asthma was identified as
obstruction, elevated lung volumes and normal diusion
for alveolar volume. Extrapulmonary cause for low lung
volume was identified as low lung volume (VA570%
predicted and TLC580% predicted if done), low vital
capacity (570% predicted) and normal diusion for
alveolar volume.
Patients with both preoperative and postoperative DLCO
tests who has lung resections from 7/94 to 4/97 were
identified. The group included one segmental resection, one
pneumonectomy and seven lobectomy patients.
STATISTICS
Linear regression analysis was performed on DLCO/
DLCOtlc vs. VA/VAtlc, on KCO/KCOtlc vs. VA/VAtlcand on KCO/KCOtlc vs. 1/(VA/VAtlc). To determine
whether age influenced the eect of lung volume on DLCO
and KCO, linear regression analyses were also performed
on the younger 12 subjects (age 30+28) and older 12
subjects (age 51+70). Student’s t-test was used to compare
the first and second measurements of DLCO or of KCO at
TLC. Mean, standard deviation and confidence interval
analysis was performed on the dierences between KCO
and DLCO values. Values are reported as mean+SD.
Results
HEALTHY SUBJECTS
As lung volume decreased DLCO fell and KCO increased
in each of the 24 subjects. DLCO varied linearly with VA
(Fig. 1). The relationship between KCO and VA was well
explained by a linear change in KCO vs. 1/VA (which
results in a curvilinear change in KCO vs. VA). The
regression equations and 95% confidence intervals for the
slopes were DLCO/DLCOtlc058042 VA/VAtlc
(R2070), CI 037 to 047 and KCO/KCOtlc043057/
(VA/VAtlc) (R2093), CI 053 to 061
The 12 younger subjects had dierent regression
coecients than did the older subjects. For the younger
subjects, DLCO/DLCOtlc064037 VA/VAtlc and
KCO/KCOtlc039062/(VA/VAtlc). For the 12 older
subjects, DLCO/DLCOtlc051050 VA/VAtlc and KCO/
KCOtlc052049/(VA/VAtlc). The results from these
equations are within 002 of those for the equations for
the entire group over the range of VA/VAtlc from 08–11,
and within 003 of those for VA/VAtlc from 07–12.
FIG. 2. Estimated DLCO and KCO as fraction of value at
TLC. The dark solid line represents the equation DLCO/
DLCOtlc058042 VA/VAtlc. The thin solid line uses
the equation DLCODm VA2/3 * Vc/(VcDm VA2/3),
which assumes that Vc stays constant and Dm increases
by VA2/3. The dashed line uses the equation DLCODm
VA * Vc/(VcDm VA), which assumes that Vc stays
constant and Dm increases proportionate to VA. Values
for VAtlc of 51, Dm of 50 and Vc of 80 are used. Over
the range of VA/VAtlc from 04–12, the values for the
first two equations are within 003 of each other. (For
abbreviations see text.)
FIG. 3. KCO and DLCO unadjusted for alveolar volume
percent predicted values (KCO vs. DLCO) in 2313
patients. KCO7 DLCO129+178% (mean+SD). (For
abbreviations see text.)
ADJUSTING DLCO AND KCO FOR ALVEOLAR VOLUME 31As expected, the slope and intercept for DLCO vs. VA
were nearly identical to the intercept and slope for KCO vs.
1/VA. Using the intercept and slope from the DLCO vs. VA
for the slope and intercept of KCO vs. 1/VA yields the
equation KCO/KCOtlc042058/(VA/VAtlc). This equa-
tion is within 1% of that determined by regression over the
range of VA/VAtlc from 04–15. equals 1 at VA/VAtlc1,
and results in KCO percent predicted for alveolar volu-
meDLCO percent predicted for alveolar volume.
There were no significant dierences between the first and
second measurements of DLCO or of KCO at TLC (ratios
of second/first values of 100+005 for both), indicating no
eect of increasing CO backpressure. There was good
agreement between lung volume determined by helium
dilution during DLCO testing and by plethysmography,
with VA/TLC962+64%. The ratio of VA by single
breath helium dilution to VA by plethysmography
(TLCestimated dead space) was 987+65%. The inspired
volume with maximal inspiration during DLCO testing was
near that of the largest VC by spirometry, with VI/
VC955+67%.
MODEL
The dependence of DLCO and KCO on VA can be
described using a model which assumes that the membrane
component of diusion changes with lung volume while the
blood component of diusion does not change. Figure 2
compares the equations DLCO/DLCOtlc058042 VA/
VAtlc and KCO/KCOtlc042058/(VA/VAtlc) to those
expected for dierent exponents for VA, and typical values
for Dm of 50 and y Vc of 80 at a TLC of 5 l. For the model
with Dm proportional to VA2/3, the empiric equation
and the model for both DLCO/DLCOtlc and KCO/KCOtlc
are within 003 of each other over the range of VA/VAtlc
from 04–12. Varying the VA from 4–61 or the y Vc from
70–90 changes the results by a few percent over this
range.
PATIENTS
Of the 2313 patients who underwent single breath DLCO
testing, 2224 (96%) also had spirometry and 1964 (85%)
had plethysmography on the same day. Twelve hundred
and eighty-five (56%) were male, 137 (6%) black and the
group’s age was 552+162 years (range 12–97 years; 15
under age 18; 85 over age 79).
There was much variation between KCO and DLCO
percent predicted values unadjusted for alveolar volume
(Fig. 3). DLCO was lower than KCO by 129+178%.
Thirteen hundred and sixteen patients (57%) had a
discrepancy between KCO and DLCO of more than 10%,
718 (31%) a discrepancy over 20% and 371 (16%) a
discrepancy over 30%. Similar results were found using
other sets of prediction equations. DLCO was lower than
KCO by 157+187% using single breath equations for VA,
and by 118%+178% using single breath equations for
DLCO/VA. As expected, adjusting DLCO and KCO
predicted values for alveolar volume yielded nearlyidentical percent predicted DLCO and KCO values
(KCO7DLCO003+015%).
Adjusting for alveolar volume increases DLCO percent
predicted values (Fig. 4). The unadjusted DLCO is lower
FIG. 4. DLCO unadjusted for alveolar volume and DLCO
adjusted for alveolar volume percent predicted values in
2313 patients. Unadjusted DLCO underestimates DLCO
adjusted for alveolar volume for most values (values
below the solid line), with more than 10%
underestimation (values below the dashed line) for many
values. Unadjusted DLCO7adjusted DLCO737
+58% (mean+SD). (For abbreviations see text.)
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Adjusting for alveolar volume decreases KCO percent
predicted values more, with the unadjusted KCO higher
than the adjusted KCO by 91+121%.
As expected, there were clear dierences among the
groups of patients selected by PFT criteria (Tables 1 and 2).
Each group has characteristic patterns of VA and
unadjusted and adjusted DLCO and KCO percent predicted
values (Table 3). There is a clear separation among most
groups between unadjusted KCO and DLCO (Fig. 5) and
between adjusted DLCO and alveolar volume (Fig. 6).TABLE 1. PFT results among subgroups of 2313 patients [percent
probable diagnoses of emphysema, asthma, interstitial lung dis
criteria, or reported diagnosis of sarcoidosis
n FEV1
%p
FEV1/VC
%p
VC
%p
Emphysema 165 331+115 534+106 614+ 1
Asthma 22 397+ 86 599+ 68 664+1
ILD 175 559+156 1063+ 91 526+1
Extrapulmonary 36 555+132 1012+124 547+1
Sarcoidosis 122 846+197 990+111 855+1
All 2313 711+246 933+184 754+2
VC: vital capacity during spirometry test; VA: alveolar volume b
plethysmography; VI: inspired volume during DLCO test. ValueThere is some overlap between probable emphysema and
probable interstitial lung disease (ILD) patients, but most
emphysema patients had lower unadjusted KCO due to
larger VA. While the selection criteria specified that none of
the ILD group had KCO adjusted for alveolar volume
480%. 52% of the ILD group had unadjusted KCO480%
and 13% had unadjusted KCO4100%. For emphysema
patients, none (by selection criteria) had adjusted
KCO480% and only 5% had unadjusted KCO480%.
The 122 patients with recorded diagnoses of sarcoidosis
had KCO and DLCO values which overlapped those of the
ILD group and extended into the normal range. Half of
sarcoidosis patients had unadjusted DLCO480%. While
75% had unadjusted KCO480%, 60% had KCO adjusted
for alveolar volume 480%.
Lung resection patients had percent predicted results
(preoperative, postoperative) of FEV1 (79%, 62%), VC
(85%, 63%), TLC (109%, 87%), unadjusted DLCO (82%,
61%), unadjusted KCO (88%, 92%), VA (94%, 68%),
DLCO adjusted for alveolar volume (85%, 69%) and KCO
adjusted for alveolar volume (84%, 69%).
Comparison to spirometry and lung volume results
provides quality control checks on the DLCO results. The
inspired volume (VI) should be very similar to the vital
capacity. The VI of healthy subjects was 94+6% of VC.
For the entire patient group, VI was 91+13% of VC. If VI
matches VC, the DLCO test was performed at TLC. If VI is
smaller than VC, the test was performed below TLC if the
patient inspired from residual volume (RV).
Another check on the validity of the DLCO test, as well
as providing an assessment of lung volume, is to compare
VA to TLC. The VA provides the lung volume in which
helium is distributed during the DLCO test. Healthy
subjects had a VA 96+6% of their TLC determined by
plethysmography. The interstitial lung disease group had
low lung volumes, but their VA was near their TLC (VA
91+17% of TLC), as expected since there is not much
airway obstruction in the ILD group. If moderate to severe
obstruction was present. TLC was increased and the VA
was lower than TLC, being 58+15% of TLC in the
emphysema group and 68+13% of TLC in the asthmapredicted (%p) values, or percent (%)] among patients with
ease (ILD) and extrapulmonary restrictive disease by PFT
VA
%p
TLC
%p
VA/TLC
%p
VI/VC
%
57 813+194 1358+222 584+147 895+171
31 850+138 1267+145 660+125 984+158
41 611+131 667+ 99 899+174 910+134
07 615+ 77 723+ 64 859+ 88 903+133
73 869+165 986+168 866+106 916+ 88
02 856+191 1040+232 822+214 909+126
y single-breath helium dilution; TLC: total lung capacity by
s are mean +SD.
TABLE 2. DLCO and KCO results among subgroups of 2313 patients [Percent predicted for normal lung volume (unadjusted),
percent predicted for the subjects’ alveolar volume (adjusted), and dierences between predicted values]
n DLCO
unadjusted
KCO
unadjusted
DLCO
adjusted
DLCO* KCO*
(adjusted–unadjusted)
Emphysema 165 366+167 461+209 392+173 28+36 767+ 85
Asthma 22 908+124 1083+147 959+108 56+54 7117+112
ILD 175 473+125 792+215 548+138 90+36 7228+119
Extrapulmonary 36 796+ 73 1310+167 921+ 77 150+33 7360+134
Sarcoidosis 122 800+192 929+190 840+183 39+55 790+106
All 2313 716+254 845+269 755+251 37+32 791+134
Patients with probable diagnoses of emphysema, asthma, interstitial lung disease (ILD) and extrapulmonary restrictive
disease by PFT criteria, or reported diagnosis of sarcoidosis. KCO adjusted for alveolar volume values are not shown since
they are nearly identical to DLCO adjusted for alveolar volume values. *Values for all groups are significantly (P5005, t-
distribution) dierent from 0. Values are mean +SD. (For abbreviations see text.)
ADJUSTING DLCO AND KCO FOR ALVEOLAR VOLUME 33group. If steady-state helium dilution had been used instead
of plethysmography, less variation between VA and TLC
would be expected since helium dilution can underestimate
and plethysmography overestimate lung volume in the
presence of obstruction (17).
Discussion
While it is known that lung volume influences DLCO and
KCO (18,19,20,21,16), there is much confusion about how
to adjust predicted values for alveolar volume, how to
report them and their clinical significance. Some studies
propose making an adjustment for VA of reference
prediction equations (22), others propose independent
prediction equations based on sex, height, age and VA
(23), or both methods (10). This study proposes an easyTABLE 3. Pattern of DLCO percent predicted parameters among
of emphysema, asthma, interstitial lung disease (ILD), and extr
VA DLCO
(for no
Emphysema normal low
Asthma normal normal
ILD low low
Extrapulmonary low low
Lung resection low low
DLCO and KCO for normal VA use predicted values unadjuste
adjust for alveolar volume. Patients with probable diagnoses w
abbreviations see text.)method to adjust reference DLCO and KCO predicted
values for alveolar volume, how to report them, and shows
that the results have much clinical significance.
Lung volume influences DLCO and KCO (DLCO/VA),
with reductions in DLCO and increases in KCO at smaller
lung volumes in healthy subjects. There are linear relation-
ships between DLCO and VA and between KCO and 1/VA.
To adjust predicted DLCO at TLC to the patient’s alveolar
volume, the factor 058042 VA/VAtlc was determined by
regression analysis. To adjust predicted KCO at TLC the
factor 042058/(VA/VAtlc) is recommended. With these
factors and prediction equations for VA and for DLCO
used to calculate predicted DLCO/VA, the percent pre-
dicted DLCO for alveolar volume and KCO for alveolar
volume will be equal. The reductions in DLCO and
increases in KCO in the healthy subjects occur with
incomplete alveolar expansion.groups of patients with lung resection, or probable diagnoses
apulmonary lung disease
KCO DLCO KCO
rmal VA) (for patient’s VA)
low low low
normal normal normal
below 100% low low
elevated normal normal
normal low low
d for alveolar volume. DLCO and KCO for the patient’s VA
ere selected by PFT criteria from among 2313 patients. (For
FIG. 5. KCO and DLCO unadjusted for alveolar volume
percent predicted for groups of patients with probable
diagnoses of emphysema (n165), interstitial lung disease
(ILD) (n175), asthma (n22) and extrapulmonary lung
disease (n36). Patients were selected by PFT criteria
from among 2313 patients. (For abbreviations see text). ?:
emphysema; &: ILD; &: asthma; *: extrapulmonary.
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confusing. In 1914, Krogh described a permeability (k) (24)
which is the time constant of the exponential decay of CO
concentration during breath-holding. This is related to, but
dierent than DLCO/VA. DLCO/VA has been called theFIG. 6. DLCO adjusted for alveolar volume and VA
percent predicted values for groups of patients with
probable diagnoses of emphysema (n165), interstitial
lung disease (ILD) (n175), asthma (n22) and
extrapulmonary lung disease (n36). Patients were
selected by PFT criteria from among 2313 patients. (For
abbreviations see text). ?: emphysema; &: ILD; &:
asthma; *: extrapulmonary.Krogh factor (16), the ‘normalization ratio’ (25), KCO and
diusion coecient (26). KCO is recommended as a shorter
term for DLCO/VA.
This study found that the eect of lung volume on DLCO
was modest, with a 24% fall in VA needed to produce a
10% fall in DLCO. The eect on KCO is larger, with a 24%
fall in VA causing a 20% increase in KCO. Thus unadjusted
prediction equations underestimate a patient’s DLCO (%
predicted) and over-estimate a patient’s KCO (% predicted)
when the lung volume is below TLC.
The reduction in DLCO at lower lung volumes is
primarily due to lower membrane diusion with pulmonary
capillary blood volume remaining relatively constant
(16,27,28). Anatomic studies show that alveolar membrane
thickness changes little as lung volume changes (29). The
changes in DLCO with increased inspired volumes do not
appear related to changing regional distribution (30).
DLCO and KCO increase immediately after a deep breath
compared to after 10 min of tidal breathing (31). There is
hysteresis, with DLCO being higher when a lung volume is
reached by exhalation compared to inhalation (21). This
may be related to more bulging of capillaries into alveoli on
deflation (32).
Lung volume primarily aects the membrane conduc-
tance component (Dm), with much smaller changes in
capillary blood volume (Vc) (16,27,28). When the relation
of lung volume to the membrane conductance component
(Dm) of DLCO was studied, dierent relations were found,
with an exponent between 06 and 10 for most individuals
(16). The linear relationship between DLCO and VA found
in this study matched very closely those predicted from a
model in which the membrane conductance component of
diusion varies with surface area.
Stam et al. (10) found an age dependence of the volume
dependence of KCO. Younger healthy subjects had a
greater rise in KCO as volume decreased than older
subjects. This study confirmed these findings, with a steeper
slope of KCO vs. 1/VA in younger subjects. However, the
dierences in slopes led to only minor adjustments in DLCO
and KCO equations compared to the equations for the
entire group.
The physiological significance of DLCO/VA has been
controversial. DLCO/VA has been referred to as the
‘DLCO corrected for lung volume’ (8), implying that KCO
provides an assessment of diusion which is independent of
lung volume. However, this is not the case. Just as DLCO/
Hb does not correct DLCO for hemoglobin, DLCO/VA
does not correct DLCO for VA.
Since many lung diseases aect both gas exchange and
lung volume, prediction equations which assume a normal
TLC make it dicult to sort out how much of an
abnormality of DLCO is due to gas exchange versus how
much is due to low lung volume. Predicted values that
account for lung volume should allow better evaluation of
gas exchange.
This study found much variation between KCO and
DLCO percent predicted values unadjusted for alveolar
volume. KCO was greater then DLCO for most of the 2313
patients studied (Fig. 3). The majority of patients had a
discrepancy between KCO and DLCO of more than 10%,
ADJUSTING DLCO AND KCO FOR ALVEOLAR VOLUME 35nearly a third over 20%, and one sixth a discrepancy over
30%. Much dierent results were found when DLCO and
KCO predicted values were adjusted to account for alveolar
volume, with adjusted DLCO and KCO nearly identical.
Thus DLCO or KCO adjusted for alveolar volume provide a
single measure of diusion.
Some studies have questioned the validity of KCO to
assess disease. Kanengiser et al. (9) concluded that ‘volume
(DLCO/VA) relationships are not a measurement of
(interstitial lung) disease’. However, since they did not
adjust predicted values for alveolar volume, their study
shows that KCO values unadjusted for alveolar volume are
not very helpful. Others promote KCO as a more sensitive
test of diusion than DLCO (26,33). Agusti et al. (8) found
discrepancies between DLCO and KCO, with a better
correlation between KCO and AaDO2 and V/Q mismatch
than for DLCO in patients with interstitial lung disease. Re-
analyzing their data using the methods described in this
paper yields unadjusted DLCO of 51+15% and KCO of
99+28%. Adjusting for alveolar volume changes the
DLCO and KCO to 64+18%. Adjusted DLCO and KCO
correlated with their independent measures of gas exchange
abnormalities. Only seven of their 15 patients had KCO
unadjusted for alveolar volume under 80% predicted, while
13 of 15 patients had DLCO and KCO adjusted for alveolar
volume under 80%.
Frans et al. (22) advocate adjusting DLCO and KCO for
alveolar volume in the presence of restrictive lung disease.
They found that for patients with diuse interstitial lung
disease the arterial oxygen tension during exercise corre-
lated very well with DLCO and KCO adjusted for alveolar
volume. Our results for volume dependence of DLCO in
younger adults (age 30+28) were nearly identical to that
found by Frans et al. (22) in healthy males aged 22–41
years. They found DLCO/DLCOtlc06420358 VA/
VAtlc vs. this study’s results of DLCO/ DLCOtlc 064
037 VA/VAtlc.
Percent predicted VA, unadjusted DLCO and KCO, and
DLCO and KCO adjusted for alveolar volume show
characteristic findings depending upon the patient’s disease
as determined by PFT criteria (Tables 1, 2 and 3). Therefore,
it is very helpful for the clinical to have all these values
reported. Our laboratory reports single-breath DLCO
results with both sets of predicted values (Table 4).TABLE 4. Report of DLCO results from a 27 year old woman w
Diusion (Single Breath) Observed Pre
DLCO (ml/min/mm Hg) 239
KCO (ml/min/mm Hg/L) 76
VA (l BTPS of helium dilution) 313
Volume Inspired (l BTPS) 168
Predicteds adjusted for hemoglobin. If Hb were normal, DLCOPatients with probable emphysema had an elevated TLC,
normal or mildly low VA and low unadjusted DLCO and
KCO. Their DLCO adjusted for alveolar volume was
slightly higher than unadjusted DLCO (27+37%).
Patients with probable interstitial lung disease had low
unadjusted DLCO and a higher unadjusted KCO. Their
DLCO adjusted for alveolar volume was higher than
unadjusted DLCO by 90+36%, and KCO adjusted for
alveolar volume much lower (7228+119%) than un-
adjusted KCO. Most (87%) had an unadjusted KCO below
100%. If unadjusted KCO had been used to assess
diusion, 52% would have been called normal
(KCO480%). None had KCO adjusted for alveolar
volume 480%. Thus adjusted KCO for alveolar volume
is more sensitive than unadjusted KCO in detecting
interstitial lung disease.
Half the patients with probable extrapulmonary disease
had unadjusted DLCO below 80% and thus could have
been misidentified as having abnormal diusion. Sixty-nine
percent had a supernormal (4120%) unadjusted KCO. The
group’s DLCO adjusted for alveolar volume was higher
than unadjusted DLCO by 150+32%, and KCO adjusted
for alveolar volume much lower (7360+134%) than
unadjusted KCO. These findings are similar to those of
patients with scoliosis (34).
Patients after lung resection had low unadjusted DLCO,
normal unadjusted KCO values and low adjusted DLCO
and KCO values. Recruitment of pulmonary vasculature in
the remaining lung could account for increased unadjusted
KCO. Since lung resection reduces overall gas exchange, the
adjusted DLCO and KCO decrease.
In summary, it is important to adjust DLCO and KCO
for alveolar volume. DLCO falls and KCO rises as
lung volume becomes smaller in both healthy subjects
and models. While unadjusted DLCO and KCO percent
predicted values are often much dierent, values adjusted
for alveolar volume are nearly identical and provide a
measure of diusion that accounts for lung volume.
Dierent pulmonary diseases have characteristic patterns
of VA and unadjusted and adjusted DLCO and
KCO. Therefore, it is helpful to report both unadjusted
and adjusted values. DLCO and KCO unadjusted for
alveolar volume can be misleading in patients with low
lung volume. Unadjusted KCO often over-estimates diu-ith pectus excavatum
dicted % Pred Predicted % Pred
(for normal VA) (for patient’s VA)
275 87 218 109
45 169 70 109
609 51
449 37
would be 241
36 D. C. JOHNSONsion in patients with interstitial lung disease or extra-
pulmonary restriction, while unadjusted DLCO often
underestimates diusion. Adjusting for alveolar volume
helps determine how much of an abnormality of DLCO is
due to abnormal gas exchange versus due to low lung
volume. DLCO and KCO adjusted for alveolar volume
better assess the lung’s intrinsic ability to perform gas
exchange.
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